Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levosimendan and Global Longitudinal Strain Assessment in Cardiogenic Shock Sepsis (GLASSES 1): a Study Protocol for an Observational Study

NCT04141410 is registered in ClinicalTrials.gov with Azienda USL Toscana Centro as lead sponsor.

NCT NCT04141410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04141410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levosimendan and Global Longitudinal Strain Assessment in Cardiogenic Shock Sepsis (GLASSES 1): a Study Protocol for an Observational Study
Lead sponsor
Azienda USL Toscana Centro
Phase
Observational
Overall status
Unknown status
Start date
October 21, 2019
Completion date
January 21, 2021
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, sepsis, septic shock